Thyroid Cancer Awareness Month 2026: Understanding a Cancer That May Begin Silently

A small, painless lump in the neck can be easy to overlook, especially when it does not affect daily life. However, in some cases, such a lump may be the first sign of thyroid cancer. During its early stages, the disease generally presents little to no symptoms, and is often diagnosed during a routine medical examination or an imaging test performed for another reason. With cases of thyroid cancer increasing all over the world, it is important for everyone to know about its early signs and when to seek medical care.

Observed throughout September, Thyroid Cancer Awareness Month 2026 aims to improve understanding of the disease, encourage appropriate evaluation of suspicious symptoms and support people undergoing diagnosis, treatment and long-term follow-up. It is also an opportunity to address an important point: while thyroid cancer is often treatable, not every thyroid nodule is cancerous and not every diagnosed cancer requires the same treatment.

What is Thyroid Cancer Awareness Month?

September is recognised as Thyroid Cancer Awareness Month. During the month, healthcare institutions, patient-support organisations, medical professionals and survivors work to increase public knowledge about thyroid cancer and the importance of appropriate medical care.

The observance focuses on several priorities including:

• Helping people recognise possible warning signs
• Encouraging timely evaluation of neck lumps and related symptoms
• Correcting misconceptions about thyroid nodules
• Explaining the differences between the various types of thyroid cancer
• Promoting informed and individualised treatment decisions
• Supporting patients during treatment and long-term follow-up
• Highlighting continued developments in thyroid cancer research

Awareness should encourage timely care without creating unnecessary fear. Most thyroid nodules are not cancerous, and population-wide screening can lead to the diagnosis and treatment of very small cancers that may never have caused harm. The goal is therefore not indiscriminate testing, but informed assessment based on symptoms, examination findings, medical history and professional advice.

Understanding the Thyroid Gland[AS1]

The thyroid is a small, butterfly-shaped gland located at the front of the neck, below the voice box. It produces hormones that help regulate several essential functions, including metabolism, body temperature, heart rate and energy use.

Different cells within the thyroid perform different functions. Most thyroid cancers begin in follicular cells, which produce and store thyroid hormones. Medullary thyroid cancer develops in parafollicular or C cells, which produce the hormone calcitonin.

Thyroid cancer occurs when cells in the gland develop abnormal changes and begin growing uncontrollably. These cells may form a tumour, invade nearby tissues or spread to lymph nodes and other parts of the body. How the disease behaves depends considerably on the type of thyroid cancer involved.

What are the Main Types of Thyroid Cancer?

There are four principal types of thyroid cancer: papillary, follicular, medullary and anaplastic. They differ in how commonly they occur, how quickly they tend to grow and how they are treated.

Papillary Thyroid Cancer

Papillary thyroid cancer is the most common type. It usually grows slowly and often responds well to treatment, particularly when identified before it has spread extensively.

It may spread to lymph nodes in the neck, but this does not necessarily carry the same implications as lymph-node involvement in many other cancers. Treatment and outlook still depend on factors such as age, tumour size, tumour characteristics and the extent of disease.

Follicular Thyroid Cancer

Follicular thyroid cancer also begins in the thyroid’s follicular cells. It is less common than papillary cancer and may be more likely to spread through the bloodstream to organs such as the lungs or bones.

Papillary, follicular and oncocytic thyroid cancers are collectively described as differentiated thyroid cancers because their cells retain some characteristics of normal thyroid tissue.

Medullary Thyroid Cancer

Medullary thyroid cancer develops in the thyroid’s C cells. These cells produce calcitonin, so measuring this hormone in the blood may help with diagnosis and follow-up.

Some cases occur sporadically, without a recognised inherited cause. Others are linked to inherited changes in the RET gene and may occur as part of multiple endocrine neoplasia type 2. Genetic counselling and testing may therefore be recommended for people diagnosed with medullary thyroid cancer and, when relevant, their relatives.

Anaplastic Thyroid Cancer

Anaplastic thyroid cancer is rare but highly aggressive. It can grow quickly and affect nearby structures in the neck, potentially causing swallowing or breathing difficulties.

Because the disease may progress rapidly, urgent evaluation and coordinated treatment are important. Molecular testing of the tumour may identify changes that can be targeted with particular medicines in some patients.

What are the Symptoms of Thyroid Cancer?

Thyroid cancer often presents as a thyroid nodule or lump and may not cause any other symptoms initially. Thyroid-function blood tests can remain normal even when cancer is present.

Possible symptoms include:

• A new lump or swelling at the front of the neck
• An existing neck lump that appears to be growing
• Swollen lymph nodes in the neck
• Persistent hoarseness or a change in the voice
• Difficulty swallowing
• A sensation of pressure or tightness in the neck
• Difficulty breathing
• Persistent pain in the front of the neck, sometimes extending towards the ears
• An unexplained cough not associated with a respiratory infection

These symptoms do not automatically indicate cancer. Thyroid nodules are common and are usually benign. Infections, non-cancerous thyroid enlargement and other conditions can also cause changes in the neck.

Nevertheless, a new or enlarging lump, persistent hoarseness, swallowing difficulty or another unexplained neck symptom should be assessed by a healthcare professional. Rapidly increasing swelling or significant breathing difficulty requires urgent medical attention.

What Increases the Risk of Thyroid Cancer?

A risk factor increases the likelihood of developing a disease but does not mean that the disease will definitely occur. Some people with thyroid cancer have no obvious risk factors, while many people with one or more risk factors never develop it.

Recognised risk factors include:

• Exposure to ionising radiation: Radiation exposure involving the head and neck, particularly during childhood, can increase thyroid cancer risk. This may include previous radiotherapy for another illness or exposure during a nuclear accident.
• Family history: Having a close family member with thyroid cancer may increase risk, particularly when an inherited cancer syndrome is involved.
• Inherited genetic conditions: Certain inherited changes, including those involving the RET gene, are associated with medullary thyroid cancer. Other familial syndromes may also increase the likelihood of particular thyroid tumours.
• Age and sex: Thyroid cancer can occur at any age, but certain types are more common within particular age groups. It is diagnosed more frequently in women than in men, although the reasons for this difference are not fully understood.
• Iodine availability: Long-term iodine deficiency has been associated with a greater risk of follicular thyroid cancer. The relationship between iodine and different thyroid diseases is complex, and people should not take iodine supplements for cancer prevention without medical advice.

A person’s risk cannot be judged from any one factor alone. A healthcare professional considers the complete clinical picture, including symptoms, examination findings, medical history and family history.

How is Thyroid Cancer Diagnosed?

Evaluation usually begins with a physical examination of the neck. The doctor may assess the thyroid gland, the characteristics of any lump and whether nearby lymph nodes appear enlarged.

Further investigation may include the following.

Imaging and Additional Tests

Computed tomography, magnetic resonance imaging, nuclear medicine scans or other tests may be used when doctors need more information about the tumour or whether it has spread.

Blood calcitonin testing and genetic evaluation may be appropriate when medullary thyroid cancer is suspected. Molecular testing of biopsy or tumour tissue can also help guide diagnosis or treatment in selected cases.

How is Thyroid Cancer Treated?

Treatment depends on the type and stage of cancer, tumour size, molecular features, the patient’s age and general health, and whether the disease has spread. Personal preferences also matter, particularly when more than one reasonable approach is available.

A. Active Surveillance

Immediate surgery may not always be necessary for a very small, low-risk papillary thyroid cancer that is confined to the thyroid and not close to critical structures. Under active surveillance, the patient undergoes scheduled ultrasound examinations and clinical reviews.

Active surveillance is not the same as ignoring the disease. It is a structured approach intended to avoid unnecessary treatment while watching carefully for changes that may require intervention.

B. Surgery

Surgery is the main treatment for many thyroid cancers. Depending on the tumour, the surgeon may remove:

• One thyroid lobe, known as a lobectomy
• Most or all of the thyroid gland, known as a thyroidectomy
• Nearby lymph nodes when there is confirmed or suspected involvement

Possible complications include bleeding, voice changes caused by injury to the nerves supplying the vocal cords and low calcium levels if the parathyroid glands are affected. These risks vary according to the operation and should be discussed with the surgical team.

C. Radioactive Iodine Therapy

Some differentiated thyroid cancers absorb iodine. Radioactive iodine may therefore be used after surgery to destroy remaining thyroid tissue or treat cancer that has spread.

It is not required for every patient and is not effective against all thyroid cancer types. Its use depends on the likelihood of recurrence, tumour characteristics and whether the cancer is expected to take up iodine.

D. Thyroid Hormone Therapy

People who undergo total thyroidectomy require lifelong thyroid hormone replacement. The medicine replaces hormones that the thyroid can no longer produce.

In some patients with differentiated thyroid cancer, the dose may also be adjusted to suppress thyroid-stimulating hormone, which can encourage the growth of certain thyroid cancer cells. The appropriate level of suppression depends on the individual’s recurrence risk and potential side effects.

E. External-Beam Radiotherapy and Systemic Treatments

External-beam radiotherapy may be considered when surgery is not possible, when cancer remains in the neck or when symptom control is required.

For advanced, recurrent or radioactive iodine-resistant disease, targeted medicines may be used to interfere with specific pathways that help cancer cells grow. Chemotherapy is used less commonly, while immunotherapy and new treatment combinations continue to be studied. NCI lists surgery, radioactive iodine, hormone therapy, radiotherapy, targeted therapy and, in selected circumstances, chemotherapy among the available treatment approaches. (NCI)

Thyroid Cancer Awareness month at RGCIRC

Thyroid Cancer Awareness Month 2026 is an opportunity to replace uncertainty with informed action. Most thyroid nodules are not cancerous, but a new or enlarging neck lump, persistent hoarseness, difficulty swallowing or unexplained neck symptoms should not be ignored. At the same time, appropriate evaluation is important so that patients are not exposed to unnecessary tests or treatment.

At Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), thyroid cancer care brings together specialists across surgical oncology, medical oncology, radiation oncology, radiology, pathology, nuclear medicine and supportive care. This multidisciplinary approach helps ensure that diagnosis and treatment are tailored to the type and extent of thyroid cancer, while patients and families receive clear guidance and compassionate support throughout care.[AS2]

To consult a cancer specialist at Rajiv Gandhi Cancer Institute & Research Centre, call +91-11-47022222 or visit www.rgcirc.org.

Frequently Asked Questions

1. When is Thyroid Cancer Awareness Month 2026?

Thyroid Cancer Awareness Month is observed throughout September. It focuses on improving understanding of thyroid cancer, encouraging appropriate evaluation of suspicious symptoms and supporting people affected by the disease.

2. Does every thyroid nodule need a biopsy?

No. Most thyroid nodules are benign, and not every nodule requires a biopsy. Doctors consider factors such as the nodule’s size, ultrasound appearance, medical history and other clinical findings before deciding whether fine-needle aspiration is needed.

3. Can thyroid cancer occur even when thyroid-function tests are normal?

Yes. Many people with thyroid cancer have normal thyroid hormone levels. Thyroid-function tests show how well the gland is working, but they cannot by themselves confirm or rule out thyroid cancer.

4. Can thyroid cancer run in families?

Most thyroid cancers are not inherited. However, some forms, particularly medullary thyroid cancer, may be linked to inherited changes in the RET gene. Genetic counselling and testing may be recommended when an inherited condition is suspected.

5. Does everyone with thyroid cancer need the entire thyroid removed?

No. The extent of surgery depends on the cancer type, tumour size, location, risk of recurrence and whether the disease has spread. Some patients may require removal of only one thyroid lobe, while others may need a total thyroidectomy.

6. Is radioactive iodine required after every thyroid cancer surgery?

No. Radioactive iodine is mainly used for selected differentiated thyroid cancers and is not necessary for every patient. Its use depends on the cancer’s characteristics, recurrence risk and whether the tumour is expected to absorb iodine.